CytoDyn Inc. (CYDY) › Shareholders' EquityCytoDyn Inc. (CYDY) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2003: -$145.2K2004: -$1202005: -$759.8K2006: -$651.0K2007: -$1.07M2008: -$1.65M2009: -$2.25M2010: -$3.22M2011: -$5.01M2012: -$3.97M2013: -$223.9K2014: $3.92M2015: -$10.69M2016: $10.21M2017: -$1.10M2018: -$13.16M2019: -$8.91M2020: -$2.48M2021: -$21.02M2022: -$94.40M2023: -$109.50M2024: -$116.76M2025: -$96.04M-$96.04M2003Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$96.04M+17.7%2024-$116.76M-6.6%2023-$109.50M-16.0%2022-$94.40M-349.1%2021-$21.02M-747.2%2020-$2.48M+72.2%2019-$8.91M+32.3%2018-$13.16M-1092.7%2017-$1.10M-110.8%2016$10.21M+195.4%2015-$10.69M-372.6%2014$3.92M+1851.7%2013-$223.9K+94.4%2012-$3.97M+20.7%2011-$5.01M-55.7%2010-$3.22M-43.0%2009-$2.25M-36.6%2008-$1.65M-53.2%2007-$1.07M-65.0%2006-$651.0K+14.3%2005-$759.8K-633035.8%2004-$120+99.9%2003-$145.2K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share